Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Saffron Extract
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Université Catholique de Louvain
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Effect of a Combination of Plants to Regulate Mood
Details : Saffron Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Mood Regulation.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
November 18, 2023
Lead Product(s) : Saffron Extract
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Université Catholique de Louvain
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saffron Extract
Therapeutic Area : Sleep
Study Phase : Undisclosed
Sponsor : Université Catholique de Louvain
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Effects of Saffron Extract on Sleep Quality and Stress
Details : Saffron is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Sleep Initiation and Maintenance Disorders.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 11, 2021
Lead Product(s) : Saffron Extract
Therapeutic Area : Sleep
Highest Development Status : Undisclosed
Sponsor : Université Catholique de Louvain
Deal Size : Inapplicable
Deal Type : Inapplicable